Jacques Camonis

Centre National de la Recherche Scientifique — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

65h-index17.5kcitations262works12.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hippo pathway signaling and YAP/TAZ(47), Protein Kinase Regulation and GTPase Signaling(35), Signaling Pathways in Disease(33), Cancer-related gene regulation(27), Cellular transport and secretion(26)

Publications261 total

A review and perspective paper: Ras oncogene gets modest, from kingpin to mere henchman
Cellular and Molecular Life Sciences·2024· 3 citedOpen Access
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Cell Reports Medicine·2024· 28 citedOpen Access
YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer
Molecular and Cellular Biochemistry·2024· 6 cited
YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer
Research Square (Research Square)·2023Open Access
<i>Ex vivo</i> quantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chip
2023Open Access
WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
Cancer Gene Therapy·2023· 4 citedOpen Access
Supplementary Figure Legends 1-5 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 3 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 2 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Table 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 4 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Table 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 3 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Data from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 1 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Data from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 2 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 4 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
Supplementary Figure 5 from High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Carine Rossé(10), Étienne Formstecher(8), Michael A. White(7), Laurent Daviet(5), Philippe Chavrier(4), Gladys Mirey(4), Michael Wigler(3), Serge A. Moskalenko(3), Charles Yeaman(3), Francisco Romero(3), A Tavitian(3), François Lallemand(3), Sébastien L’Hoste(3), Gérard Zalcman(3), Mark Boldin(2), Eugene Varfolomeev(2), Igor Mett(2), David Wallach(2), Sandra Aresta(2), Vincent Collura(2)